(Alliance News) - London's FTSE 100 closed just the wrong side of the line on Tuesday, bucking a more upbeat global mood, weighed by sharp falls in AstraZeneca and Schroders. Read More
AstraZeneca PLC - Cambridge, England-based pharmaceutical company - Reports that AstraZeneca China President Leon Wang is cooperating with an ongoing investigation by Chinese authorities. Wang is also executive vice president of the International division. "Our China operations continue under the leadership of the current general manager of AstraZeneca China. If requested, AstraZeneca will fully cooperate with the investigation," the company says. Read More
(Alliance News) - AstraZeneca PLC on Monday welcomed approval in the European Union of Fasenra for the treatment of eosinophilic granulomatosis with polyangiitis. Read More
(Alliance News) - London's FTSE 100 is called to open higher on Monday, after decent trade in Asia at the start of the week, while the yen sank on political uncertainty in Japan. Read More
(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis. Read More
(Alliance News) - Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in patients with a form of lung cancer. Read More
(Alliance News) - Stock prices in London were lower at midday on Monday, as investors wait for a number of inflationary prints later in the week. Read More
(Alliance News) - Stock prices in London opened just about higher on Monday morning, inching up despite disappointing data from China, and reports of new restrictions on the UK gambling sector. Read More
(Alliance News) - London's FTSE 100 moved higher on Wednesday morning, shaking off nervy trade in China, where stimulus disappointment weighed on the mood. Read More
(Alliance News) - AstraZeneca PLC on Monday entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd to advance the development of an early stage, novel small molecule lipoprotein disruptor for patients with dyslipidaemia. Read More
(Alliance News) - AstraZeneca PLC on Monday said an independent data monitoring committee recommended an early trial stop for its medication Airsupra due to overwhelming efficacy at pre-planned analysis for the treatment of asthma. Read More
(Alliance News) - AstraZeneca PLC on Thursday said its cancer treatment Calquence obtained priority review by the US Food & Drug Administration for a form of lymphoma. Read More
(Alliance News) - Stock prices in London were predominantly lower at midday on Wednesday, though the FTSE 100 continued in the green, thanks to its exposure to the oil and defence sectors. Read More
(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the Food & Drug Administration in the US for some forms of breast cancer. Read More
(Alliance News) - Stock prices in London opened a mixed bag in London on Tuesday, with the FTSE 100 in the green, but compatriot indices in the red, ahead of a slew of manufacturing PMIs later in the day. Read More